PPHVanEck Pharmaceutical ETF
Seeks to replicate the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index.
By VanEck · Launched 2011
Annual Cost
0.36%
#1,773 of 5,854 · low cost
Fund Size
$879M
#1,202 of 5,854 · large
Return (1Y)Goal
+31.6%
Track Record
14 years
#933 of 5,854 · established
Performance
Total-return NAV · USDGrowth of $10,000
$12,522+25.2%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Multi cap
Strategy
Index tracking
Sector
Health careFocus
Pharmaceuticals
Index tracked
MVIS US Listed Pharmaceutical 25 Index
What it actually holds
By weightConcentration
Top 10 holdings = 71.8% of fundconcentrated
Eli Lilly & Co
18.7%
Novartis AG
10.8%
Merck & Co Inc
9.7%
Pfizer Inc
5.2%
Novo Nordisk A/S
4.8%
Sanofi SA
4.7%
Bristol-Myers Squibb Co
4.6%
GSK PLC
4.6%
AstraZeneca PLC
4.4%
Johnson & Johnson
4.3%
Asset allocation
Stocks
99.9%
Cash
0.1%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
18.2%Moderate
Year-on-year price swings
Max drawdown
-29.7%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.64Decent risk-adjusted returns
Sortino (3Y)
0.94Moderate downside risk
Listing
- Exchange
- NASDAQ Global Select Market
Full fund details
- Objective
- Seeks to replicate the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index.
- Strategy
- Uses a passive investment approach to replicate the Pharmaceutical Index by investing at least 80% of total assets in common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry, including medium-cap companies. Concentrates investments in the pharmaceutical sector to match the index's composition.
- Inception date
- December 20, 2011
- Fund family
- VanEck
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at PPH. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-03